|
|
Merck And Co Inc 's Yearly Net Income Growth 5 Years |
|
Select the Comparisons :
|
|
Select the Ratio:
|
Annual Net Income Annual Growth Rates Y/Y▼
|
Annual Net Income Annual Growth Rates Y/Y▼
|
MRK Annual Net Income Growth |
2023
|
2022
|
2021
|
2020
|
2019
|
Y / Y Annual Net Income Change |
-97.49 % |
11.21 % |
84.44 % |
-27.56 % |
57.87 % |
Annual Net Income (in millions $) |
$365.00 |
$14,526.00 |
$13,062.00 |
$7,082.00 |
$9,777.00 |
Annual Net Income Growth
Comment |
Merck And Co Inc experienced detoriation of Annual Net Income for the fiscal year ended 2023 by -97.49% to $ 365.00 millions, compare to $ 14,526.00 in Annual Net Income reported in the previous year. The decline in company's annual Net Income accelerated, from the 11.21 % gain, in the fiscal year ended 2022.
Merck And Co Inc Annual Income Statement
|
You need to upgrade your Flash Player
|
Companies with similar 2023 Annual Net Income within Healthcare Sector | Y/Y Net Income Growth % | 2023 Annual Net Income | Pfizer Inc | -93.13 % | $ 2,158.000 millions | Biontech Se | -90.14 % | $ 1,041.936 millions | Vertex Pharmaceuticals Inc | 8.96 % | $ 3,619.600 millions | Biogen Inc | -60.78 % | $ 1,161.500 millions | Stryker Corp | 34.22 % | $ 3,165.000 millions | Zoetis Inc | 10.85 % | $ 2,340.000 millions | Viatris Inc | -97.37 % | $ 54.700 millions | Becton Dickinson And Company | -16.58 % | $ 1,484.000 millions | Takeda Pharmaceutical Company Limited | 30.34 % | $ 2,196.436 millions | Edwards Lifesciences Corporation | -8.05 % | $ 1,399.400 millions | Intuitive Surgical Inc | 35.18 % | $ 1,817.300 millions | Agilent Technologies inc | -1.12 % | $ 1,240.000 millions | Iqvia Holdings Inc | 24.47 % | $ 1,358.000 millions | Quest Diagnostics Inc | -10.54 % | $ 908.000 millions | Fresenius Medical Care Ag | -18.10 % | $ 820.353 millions | Tenet Healthcare Corp | 30.97 % | $ 1,311.000 millions | Organon and Co | 11.56 % | $ 1,023.000 millions | Mettler toledo International Inc | -9.60 % | $ 788.778 millions | Davita Inc | 22.43 % | $ 956.978 millions | Resmed Inc | 15.15 % | $ 897.556 millions | United Therapeutics Corporation | 35.40 % | $ 984.800 millions | Boston Scientific Corporation | 128.08 % | $ 1,592.000 millions | Idexx Laboratories Inc | 24.44 % | $ 845.042 millions | Revvity Inc | 21.77 % | $ 693.094 millions | Icon Plc | 144.76 % | $ 1,236.802 millions | Alcon inc | 190.75 % | $ 974.000 millions | Envista Holdings Corporation | | | |